New breast cancer drug gives hope to Irish women

A NEW drug offering fresh hope to women with an aggressive form of breast cancer has been approved for use in record time by the European Commission.

It took just 27 days for the commission to authorise the application for the cancer fighting drug called Herceptin because data on its effectiveness in treating early stage HER2-positive breast cancer is so compelling.

The approval will ensure that every woman in Ireland with early stage HER2-positive breast cancer will have access to the lifesaving treatment.